Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/15/2008CN101283983A Stable camptothecine liposome composition
10/15/2008CN101283982A Fenofibrate nanometer suspension and preparation method thereof
10/15/2008CN101283981A Sustained-release injection containing antibiotic
10/15/2008CN101283980A Propylgallate and sodium chloride injection
10/15/2008CN101283979A Preparation method of hyaluronic acid small fragment plaster for promoting the wound healing
10/15/2008CN101283973A Sustained-release injection containing netilcosin
10/15/2008CN101283972A Sustained-release injection containing antibiotic and application thereof
10/15/2008CN101283971A Sustained-release injection containing antibiotic lincomycin and application thereof
10/15/2008CN101283970A Sustained-release injection containing antibiotic and application thereof
10/15/2008CN101283969A Sustained-release injection containing estomycin
10/15/2008CN101283968A Tolterodine fumarate oral solid preparation and preparation method thereof
10/15/2008CN101283965A Preparation containing bendopa methyl ester and preparation method thereof
10/15/2008CN101283807A PUFA supplements
10/15/2008CN100425702C Lentiviral triplex DNA, and vectors and recombinant cells contg. same
10/15/2008CN100425621C Steroid imidazole salt compound and its preparing process
10/15/2008CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/15/2008CN100425603C Compound with anti cerebralischemia, myo cardialischemia and memory-improving functions, and its preparing method and use
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425594C PPAR-activating compound and pharmaceutical composition comprising the compound
10/15/2008CN100425592C Indole derivatives
10/15/2008CN100425591C Sulfonyl diphenylethyllene endocompound and its preparation method and pharmaceutical uses
10/15/2008CN100425291C O-type foot-and-mouth disease virus poly-gene duplication defect type adenovirus active carrier vaccine and process for preparing the same
10/15/2008CN100425289C Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin
10/15/2008CN100425263C Gastric medicine and its preparation method
10/15/2008CN100425252C Medicine for treating leukopenia
10/15/2008CN100425248C Externally-applied colliculus musk-oil agent for treating burn and scald
10/15/2008CN100425246C Anti-dust nasal cleanser
10/15/2008CN100425243C Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis
10/15/2008CN100425242C Erigeron breviscapus effervescent dry mixed suspension and its making method
10/15/2008CN100425241C Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin
10/15/2008CN100425240C Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabi
10/15/2008CN100425239C Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
10/15/2008CN100425238C Medicine for treating burns
10/15/2008CN100425237C Compound cetirizine hydrochloride gel
10/15/2008CN100425236C Use of cuminum cyminum extract and piperine for potentiaion of bioeffectacy of anti infectives
10/15/2008CN100425235C Enteric omeprazole micropill and its preparing method
10/15/2008CN100425234C Pharmaceutical composition containing anti-ulcerative drug and mucosa-protecting agent for treating gastrosis
10/15/2008CN100425233C Nimodipine gel for nasal cavity
10/15/2008CN100425232C Buccale tablet preparation and its making method
10/15/2008CN100425231C Oral formulation of danshensu and safflower yellow and preparation process thereof
10/15/2008CN100425230C Use of flavone substance or triterpene compound for treating thyreoidism
10/15/2008CN100425229C Local medicine preparation containing antiinfective medicine composition and its preparing method
10/15/2008CN100425228C Dispersion tablets and its prepn. method
10/15/2008CN100425146C Higher unsaturated fatty acid composition
10/14/2008US7435838 Mixture of both S- and R-enantiomers of 3-hydroxymethyl-4-[1-(p-fluorophenyl)-1-hydroxyl-4-(dimethylamino)]butylbenzonitrile; dissolving the intermediate free base oil in a single- or multi-component solvent, and crystallizing one or more times
10/14/2008US7435834 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/14/2008US7435833 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
10/14/2008US7435832 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions
10/14/2008US7435831 Bicyclic and bridged nitrogen heterocycles
10/14/2008US7435830 Bicyclic and bridged nitrogen heterocycles
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435828 immunosuppressive agents; low dosages; 5-[4-(2-hydroxy-ethoxy)-benz[Z]ylidene]-2-([Z]-isopropylimino)-3-o-tolyl-thiazolidin-4-one
10/14/2008US7435827 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435819 4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-C] pyridine-3-thione compounds
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435812 Method for preparing a glucosamine compound and compound thus obtained
10/14/2008US7435805 O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
10/14/2008US7435757 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
10/14/2008US7435756 Preparation and diabetic use of gibberellins
10/14/2008US7435755 Inducing cytotoxicity in a cell comprising contacting with a CDDO-compound and a chemotherapeutic agent
10/14/2008US7435754 Laulimalide microtubule stabilizing agents
10/14/2008US7435753 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; Coupling of an aryldiazonium salt with a 2,3-dicyano-3-cyclopropyl propanoate; parasiticides; fleas; Extended duration of action for at least 28 days
10/14/2008US7435752 N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benozioc acids as HIV reverse transcriptase inhibitors
10/14/2008US7435751 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435749 Beverage treated with nicotine
10/14/2008US7435748 Alzheimer's disease; bridged bicycloalkyl spirocyclic sulphonamide derivatives; oral administration
10/14/2008US7435747 Guanidine and amidine derivatives as factor Xa inhibitors
10/14/2008US7435746 4-{2-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-6-oxo-piperidin-1-yl]-ethylsulfanyl}-butyric acid or the methyl ester; glaucoma, intraocular hypotensive agents
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435741 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
10/14/2008US7435740 e.g. 1-Benzyl-7-phenyl-3-propyl-1H-pyrrolo[1,2-f]purine-2,4(3H,6H)-dione; antiinflammatory, anticarcinogenic agent; cerebral ischemia, asthma, neurodegeneration, glaucoma, ischemic heart pre-conditioning; diagnostic agents
10/14/2008US7435739 Antiproliferative agents; skin, prostate glands, kidneys, central nervous system
10/14/2008US7435738 Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008US7435735 Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
10/14/2008US7435733 Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
10/14/2008US7435732 Crystalline polymorphs of (3S)-N-hydroxy-4-({4-[-(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide
10/14/2008US7435731 Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same
10/14/2008US7435730 Short-acting benzodiazepines
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435728 Pyrazole derivatives
10/14/2008US7435727 Incubating biomaterial with radiolabeled, photoreactive 2-azetidinone compound; solubilizing and forming eluent of supernatant and wheat germ lectin agarose; separating using column chromatography and gel electrophoresis
10/14/2008US7435726 Thalidomide and a topoisomerase inhibitor anticancer drug such as irinotecan; reduces toxicity related side effects of anticancer drug
10/14/2008US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/14/2008US7435722 injection of curing agents selected from genipin, proanthocyanidin, ribose, threose, and lysyl oxidase into the convex side of intervertebral discs, to reduce bending hysteresis and increasing bending stiffness
10/14/2008US7435720 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008US7435432 Plant and cartilage extracts, wherein plant extract comprises grape seed extract and tomato extract; anti-oxidant effect, free-radical inhibition
10/14/2008US7435429 Zinc salt compositions for the prevention of dermal and mucosal irritation
10/14/2008US7435427 Contains at least 2 lipidic excipients, one of them being an hydrophilic excipient (having a high HLB value) and the other an oily excipient; stearoyl macroglyceride and soyabean oil for example
10/14/2008US7435419 Methods of diagnosing and treating pre-eclampsia or eclampsia
10/14/2008US7435413 Using blood coagulation factor to identify antibodies which modulate, prevent and treat tumors, inflammation, septic shock, hypotension and adult respiratory distress syndrome
1 ... 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 ... 7860